Jefferies Financial Group
CLYM icon

Jefferies Financial Group’s Climb Bio CLYM Stock Holding History

Jefferies Financial Group’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.34M Buy
+290,850
New +$4.05M 0.02% 411

Other funds holding CLYM

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Jefferies Financial Group's CLYM Position: Q3 2026 in Review

Jefferies Financial Group opened a new position in Climb Bio (CLYM) in Q3 2026: 290,850 shares worth $3.34M. The stake represents 0.02% of the portfolio and ranks #411 among its holdings.

26 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.

  • Jefferies Financial Group held 290,850 shares of Climb Bio worth $3.34M as of Q3 2026.
  • Climb Bio was a new Jefferies Financial Group position in Q3 2026.
  • Climb Bio made up 0.02% of Jefferies Financial Group's portfolio in Q3 2026, its #411 holding.
  • 26 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.